| Application no. and date | 19196366.9 (espacenet) (Federated) (European Patent Register), 20140122 | | Patent/reg. no. and date | DK/EP 3598971, 20240320 | | Publication date | 20200129 | | Priority no. and date | US 201361849191 P, 20130122 | | EP pub. no. and date |
EP 3598971 20200129 | | Effective date | | | Applicant/owner | Vistagen Therapeutics, Inc., 343 Allerton Avenue
South San Francisco, CA 94080, US | | Applicant ref. no. | V477142DK00 | | Inventor | Snodgrass, Ralph H., 20781 Via Corta
San Jose, CA California 95120, US,
Hicklin, Jack S., Cato Research, 6480 Weathers Place, Suite 104
San Diego, CA California 92121, US,
Cato, Allen E., Cato Research, 4364 S. Alston Avenue
Durham, CA California 27713, US | | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | | Opponent | | | IPC Class | A61K 31/198 (2006.01) , A61P 25/04 (2006.01) | | Title | Doseringsformer og terapeutiske anvendelser af L-4-chlorkynurenin | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
